← Study Library
Registry · 2003
Anecdotalcounts toward this tierSafety of Cartrophen Vet in the dog: review of adverse reaction reports in the UK
Hannon RL, Smith JG, Cullis-Hill D, Ghosh P, Cawdery MJ · The Journal of Small Animal Practice
Anecdotalcounts toward this tier
An estimated real adverse-reaction incidence of 0.074% per dose even assuming 90% underreporting, dominated by vomiting within minutes of injection and one to two days of lethargy or inappetence — mild and transitory across nine years of UK canine use.
- Population
- 161 suspected adverse-reaction reports for Cartrophen Vet filed with the UK Veterinary Medicines Directorate, 1991–1999
- Intervention
- Sodium PPS 100 mg/ml veterinary injection in routine canine practice
- Comparator
- None (pharmacovigilance review)
- Limitations
- Authored by the manufacturer (Biopharm Australia); passive surveillance underestimates true rates; canine, not human, exposure.
Cited by
1 entry references this study
- Pentosan polysulfate (PPS)PROM.
Peptides → Clinically studied